6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid

C58H72F2N12O14P3S+ — CID 166730664

IUPAC6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid
SMILESCP(O)OCCCCCCNC(=O)CCCCC(=O)N1Cc2ccccc2-c2nnn(CCCCCC(=O)NCC(=O)Nc3ccc(CSP4(=O)OC[C@H]5OC[C@H](F)[C@@H]5O[P+](=O)OC[C@H]5O[C@@H](n6cnc7c(N)ncnc76)[C@H](F)[C@@H]5O4)cc3)c2-c2ccccc21
InChIInChI=1S/C58H71F2N12O14P3S/c1-87(77)81-28-14-3-2-12-26-62-46(73)20-10-11-21-49(76)70-30-38-15-6-7-16-40(38)51-53(41-17-8-9-18-43(41)70)72(69-68-51)27-13-4-5-19-47(74)63-29-48(75)67-39-24-22-37(23-25-39)34-90-89(79)83-33-44-54(42(59)31-80-44)85-88(78)82-32-45-55(86-89)50(60)58(84-45)71-36-66-52-56(61)64-35-65-57(52)71/h6-9,15-18,22-25,35-36,42,44-45,50,54-55,58,77H,2-5,10-14,19-21,26-34H2,1H3,(H4-,61,62,63,64,65,67,73,74,75)/p+1/t42-,44+,45+,50+,54-,55+,58+,87?,89?/m0/s1
InChIKeyRQNVRIQAPZGOEZ-DJYOYWLOSA-O
MW1324.27 g/mol
LogP9.17
Rot. Bonds26

About 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid

6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid (PubChem CID 166730664) has the molecular formula C58H72F2N12O14P3S+ and a molecular weight of 1324.27 g/mol. Its IUPAC name is 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid.

Molecular Properties

Compound Name6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid
PubChem CID166730664
Molecular FormulaC58H72F2N12O14P3S+
Molecular Weight1324.27 g/mol
Exact Mass1323.42
IUPAC Name6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid
SMILESCP(O)OCCCCCCNC(=O)CCCCC(=O)N1Cc2ccccc2-c2nnn(CCCCCC(=O)NCC(=O)Nc3ccc(CSP4(=O)OC[C@H]5OC[C@H](F)[C@@H]5O[P+](=O)OC[C@H]5O[C@@H](n6cnc7c(N)ncnc76)[C@H](F)[C@@H]5O4)cc3)c2-c2ccccc21
InChIInChI=1S/C58H71F2N12O14P3S/c1-87(77)81-28-14-3-2-12-26-62-46(73)20-10-11-21-49(76)70-30-38-15-6-7-16-40(38)51-53(41-17-8-9-18-43(41)70)72(69-68-51)27-13-4-5-19-47(74)63-29-48(75)67-39-24-22-37(23-25-39)34-90-89(79)83-33-44-54(42(59)31-80-44)85-88(78)82-32-45-55(86-89)50(60)58(84-45)71-36-66-52-56(61)64-35-65-57(52)71/h6-9,15-18,22-25,35-36,42,44-45,50,54-55,58,77H,2-5,10-14,19-21,26-34H2,1H3,(H4-,61,62,63,64,65,67,73,74,75)/p+1/t42-,44+,45+,50+,54-,55+,58+,87?,89?/m0/s1
InChIKeyRQNVRIQAPZGOEZ-DJYOYWLOSA-O
XLogP9.17
TPSA326.92 Ų
H-Bond Donors5
H-Bond Acceptors23
Rotatable Bonds26
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001324.27
LogP ≤ 59.17
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid?
The IUPAC name of 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid (CID 166730664) is 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid.
What is the SMILES notation for 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid?
The canonical SMILES for 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid is CP(O)OCCCCCCNC(=O)CCCCC(=O)N1Cc2ccccc2-c2nnn(CCCCCC(=O)NCC(=O)Nc3ccc(CSP4(=O)OC[C@H]5OC[C@H](F)[C@@H]5O[P+](=O)OC[C@H]5O[C@@H](n6cnc7c(N)ncnc76)[C@H](F)[C@@H]5O4)cc3)c2-c2ccccc21.
What is the InChIKey of 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid?
The InChIKey is RQNVRIQAPZGOEZ-DJYOYWLOSA-O. The full InChI is InChI=1S/C58H71F2N12O14P3S/c1-87(77)81-28-14-3-2-12-26-62-46(73)20-10-11-21-49(76)70-30-38-15-6-7-16-40(38)51-53(41-17-8-9-18-43(41)70)72(69-68-51)27-13-4-5-19-47(74)63-29-48(75)67-39-24-22-37(23-25-39)34-90-89(79)83-33-44-54(42(59)31-80-44)85-88(78)82-32-45-55(86-89)50(60)58(84-45)71-36-66-52-56(61)64-35-65-57(52)71/h6-9,15-18,22-25,35-36,42,44-45,50,54-55,58,77H,2-5,10-14,19-21,26-34H2,1H3,(H4-,61,62,63,64,65,67,73,74,75)/p+1/t42-,44+,45+,50+,54-,55+,58+,87?,89?/m0/s1.
What are the key properties of 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid?
6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid has a molecular weight of 1324.27 g/mol, XLogP of 9.17, 26 rotatable bonds, 5 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[[6-[5-[6-[[2-[4-[[(1R,6R,9S,10R,15R,17R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5-phospha-12-phosphoniatricyclo[13.3.0.06,10]octadecan-3-yl]sulfanylmethyl]anilino]-2-oxoethyl]amino]-6-oxohexyl]-3,4,5,13-tetrazatetracyclo[13.4.0.02,6.07,12]nonadeca-1(19),2(6),3,7,9,11,15,17-octaen-13-yl]-6-oxohexanoyl]amino]hexoxy-methylphosphinous acid is sourced from PubChem (CID 166730664), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).